Key facts
- Novo Integrated Sciences, Inc. has 5 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
Insider Transactions Reported by 5 Insiders of Novo Integrated Sciences, Inc.
- Location
- Bellevue, WA
Change
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 24 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Novo Integrated Sciences, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Robert Letterio Oliva | Director | $489,863 | Filing P/S | 19 Apr 2022 | ||
| Alex Flesias | Director | Mixed | 23 Feb 2022 | |||
| Pope Michael Ross | Director | Mixed | 23 Feb 2022 | |||
| Christopher Mehlin David | Chief Operating Officer, Director | Mixed | 16 Jan 2024 | |||
| Sarfaraz Ali | Director | Mixed | 09 Aug 2022 |
Top shareholders of Novo Integrated Sciences, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Robert Letterio Oliva |
3/4/5
|
Director |
—
class O/S missing
|
217,717
|
$489,863 | — | 19 Apr 2022 | |
| Christopher Mehlin David |
3/4/5
|
Chief Operating Officer, Director |
—
mixed-class rows
|
208,195
mixed-class rows
|
— | — | 16 Jan 2024 | |
| Alex Flesias |
3/4/5
|
Director |
—
class O/S missing
|
93,995
|
— | — | 23 Feb 2022 | |
| Pope Michael Ross |
3/4/5
|
Director |
—
class O/S missing
|
93,995
|
— | — | 23 Feb 2022 | |
| Sarfaraz Ali |
3/4/5
|
Director |
—
class O/S missing
|
39,480
|
— | — | 09 Aug 2022 |
Recent Insider Transactions by Companies or Individuals for Novo Integrated Sciences, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.